Trump to reveal medical finding he calls 'answer to autism' in major announcement

President Donald Trump said he plans to reveal a significant medical and scientific finding for U.S. children on Monday, telling supporters that there may be an answer to autism. He made the remarks at a memorial service for conservative activist Charlie Kirk on Sunday, insisting that the discovery could be transformative and that people will find it amazing. The White House did not immediately provide details about the announcement, and Fox News Digital was not given additional information from federal officials at the time of publication.

White House press secretary Karoline Leavitt framed the forthcoming disclosure as connected to a broader national effort to address the autism epidemic in children. She said the announcement would illustrate how the administration aims to tackle root causes of chronic conditions while emphasizing transparency in government and adherence to “gold standard science.” The remarks came as a photo of officials in the Oval Office circulated in coverage tied to the visit of several high-profile figures, including Justice Neil Gorsuch and Robert F. Kennedy Jr., in February 2025.

The administration has signaled that the major announcement will be tied to a broader autism research initiative it had announced in April, with the goal of understanding the causes of autism by September. In parallel, the White House and health investigators are said to be evaluating whether common medications used during pregnancy could be linked to autism, with guidance reportedly expected to caution pregnant women against the routine use of acetaminophen unless a fever is present. Tylenol’s maker, Kenvue, has defended the drug as a safe option for pregnant women when used as directed, arguing that avoiding it could force patients to face more dangerous alternatives.

Health and Human Services Secretary Robert F. Kennedy Jr. has publicly attributed autism to environmental factors, arguing that exposure to an environmental toxin and a profit-driven system have contributed to the rise in cases. In April, Kennedy framed the issue as one of environmental risk and consumer incentives, saying that it is not simply a matter of biology but of policies and industry practices that made certain toxins profitable to produce and difficult for communities to avoid. His comments underscored a broader political debate surrounding environmental regulation and public health policy that has factored into the current administration’s approach to science and child health.

Context for the discussion of autism has grown sharper in recent months. A Centers for Disease Control and Prevention report released in April found that autism prevalence continues to rise, with one in 31 eight-year-old children diagnosed in 2022, up from one in 36 in 2000. Experts caution that the rise may reflect improved detection and diagnostic practices, greater access to services, and heightened awareness rather than a uniform increase in incidence. The report has fueled ongoing debates about whether environmental exposures, medical treatments, or shifts in diagnostic criteria are driving changes in diagnosed prevalence, a conversation that has intersected with health policy and political discourse.

The administration’s framing of the issue as a national priority includes signals that a large-scale research effort will seek to identify preventable risk factors and explore new treatment avenues for children affected by autism spectrum disorders. Officials cited by outlets covering the White House have described the initiative as a bipartisan, science-driven project, while critics have argued that fast-tracked science could raise concerns about transparency and the potential for political influence over public health messaging. The White House did not respond to Fox News Digital’s requests for comment on the specifics of the upcoming announcement, leaving observers to parse the available details as they emerge.

Beyond the autism research push, the notes accompanying the coverage point to a broader policy conversation about vaccine policy and public health strategy during the current administration. The ongoing national dialogue includes how best to align scientific findings with regulatory decisions and messaging to the public, particularly in the context of other chronic conditions and pediatric health debates. As Monday’s event approaches, researchers, policymakers, and families affected by autism will watch closely for any new information that could shape future health policy and funding priorities. The topic remains at the intersection of science, health policy, and politics, reflecting broader questions about how the United States prioritizes child health and how it communicates complex scientific developments to the public.